Chengdu Olymvax Biopharmaceuticals Inc.

Chengdu Olymvax Biopharmaceuticals Inc.

Share · CNE1000051H8 (XSHG)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Chengdu Olymvax Biopharmaceuticals Inc.
No Price
Closing Price XSHG 29.04.2026: 29,94 CNY
29.04.2026 07:00
Current Prices from Chengdu Olymvax Biopharmaceuticals Inc.
ExchangeTickerCurrencyLast TradePriceDaily Change
XSHG: SSE
SSE
688319.SS
CNY
29.04.2026 07:00
29,94 CNY
1,97 CNY
+7,04 %
Share Float & Liquidity
Free Float 99,59 %
Shares Float 404,06 M
Shares Outstanding 405,71 M
Company Profile for Chengdu Olymvax Biopharmaceuticals Inc. Share
Olymvax Biopharmaceuticals Inc. develops and supplies vaccines. The company offers vaccines for Tetanus, a deadly infectious disease that causes nervous system toxicity by toxigenic clostridium tetanus; and haemophilus influenzae type b. it also develops vaccines for Staphylococcus aureus, a pathogenic bacterium that causes hospital infection and community infection; and Group A streptococcus disease. The company was founded in 2009 and is based in Chengdu, China.

Company Data

Name Chengdu Olymvax Biopharmaceuticals Inc.
Company Chengdu Olymvax Biopharmaceuticals Inc.
Website https://www.olymvax.com
Primary Exchange XSHG SSE
ISIN CNE1000051H8
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Shaowen Fan
Market Capitalization 11 Mrd.
Country China
Currency CNY
Employees 0,5 T
Address No. 99 Tianxin Road, 611731 Chengdu
IPO Date 2021-06-08
Dividends from 'Chengdu Olymvax Biopharmaceuticals Inc.'
Ex-Date Dividend per Share
25.06.2024 0,04 CNY

Ticker Symbols

Name Symbol
SSE 688319.SS
More Shares
Investors who hold Chengdu Olymvax Biopharmaceuticals Inc. also have the following shares in their portfolio:
BBVA 17/22 MTN
BBVA 17/22 MTN Bond
Purpose Cash Management Fund
Purpose Cash Management Fund ETF